Filing Flows

Filing Flows › Zomedica (ZOMDF) › How it makes money

How Zomedica (ZOMDF) makes money

Zomedica (ZOMDF) made $9.9M of revenue in the third quarter 2026 (Q3 2026), +22% from a year earlier. Consumables brought in $6.8M (69%); Capital brought in $2.0M (20%); Engineering brought in $981K (10%).

Drawing the Sankey…

Zomedica revenue by segment, Q3 2026Zomedica revenue by segment, Q3 2026Consumables$6.8MCapital$2.0MEngineering$981KOther$116K
Zomedica: revenue by line, Q1 2025 to Q3 2026Zomedica: revenue by line, Q1 2025 to Q3 2026ConsumablesCapitalEngineeringOtherConsumables: $6.8M latest$6.8MCapital: $2.0M latest$2.0MEngineering: $981K latest$981KOther: $116K latestQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Capital went from 30% of revenue in Q1 2025 to 20% in Q3 2026, the largest shift in the mix.
Zomedica revenue by quarterZomedica revenue by quarter$6.5MQ1 2025$7.0MQ2 2025$8.1MQ3 2025$10.5MQ4 2025$8.8MQ1 2026$9.5MQ2 2026$9.9MQ3 2026
Zomedica: where each dollar of revenue goesZomedica: where each dollar of revenue goesIncome tax0¢

Revenue by segment, Q3 2026

SegmentRevenueShareQ/QY/Y
Consumables$6.8M68.6%+2%+26%
Capital$2.0M20.3%+9%-9%
Engineering$981K9.9%+0.2%+103%
Other$116K1.2%+158%+222%

Where each dollar of revenue goes

LineQ3 2026% of revenue
Revenue$9.9M100.0%
Income tax$9K0.1%

Revenue, quarter by quarter

QuarterRevenueY/Y
Q3 2026$9.9M+22%
Q2 2026$9.5M+37%
Q1 2026$8.8M+35%
Q4 2025$10.5M+33%
Q3 2025$8.1M+16%
Q2 2025$7.0M+14%
Q1 2025$6.5M+4%

From Zomedica's 10-Q filed Nov 4, 2026 (on EDGAR).

Questions

How does Zomedica make money?

Zomedica (ZOMDF) made $9.9M of revenue in the third quarter 2026 (Q3 2026), +22% from a year earlier. Consumables brought in $6.8M (69%); Capital brought in $2.0M (20%); Engineering brought in $981K (10%).

What is Zomedica's biggest business?

Consumables: $6.8M in the third quarter 2026, 69% of revenue, +26% from a year earlier.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.